RE:RE:RE:RE:RE:TWO STUDIES: GO !
The primary endpoint used to seek accelerated approval will be the percentage of participants achieving NASH resolution and no worsening of fibrosis compared to placebo.
Question
Do they know the targeted % and if so why would they keep this secret? Competive or else?